CLIN
Jennifer Guimbellot, MD, PhD
University of Alabama at Birmingham
Kimberly McBennett, MD, PhD
Case Western Reserve University
Cystic fibrosis care has been fundamentally changed by the advent of highly effective modulator treatment. In this session, participants will learn about updates of the long-term use of triple combination modulator therapy, the effects of such treatment on mental and physical health (across different organ systems), and the differences in impacts across the lifespan of modulator use. Furthermore, participants will gain knowledge about the impacts of modulator therapy on special populations of lung transplant recipients and during pregnancy.
Speaker: Imogen C. Felton, MRCP PhD – Adult Cystic Fibrosis Department, Royal Brompton Hospital, Guys and St Thomas' NHS Foundation Trust, London, UK.
Speaker: Susanna A. McColley, MD – Northwestern University Feinberg School of Medicine
Speaker: Rashmi Patil, MD, MPH – UPMC Children's Hospital of Pittsburgh
Speaker: Heather Bruschwein, PsyD – UVA Health System
Speaker: Deepika Polineni, MD, MPH – Washington University in St. Louis
Speaker: Sonia Graziano, Clinical Psychologist & Psychotherapist – Unit of Clinical Psychology, Bambino Gesù Children's Hospital
Speaker: Veronica Lynch – Belfast City Hospital
Speaker: Jacob Blackwelder – University of Cincinnati
Speaker: Karuna Sapru, Dr – Manchester University NHS Foundation Trust
Speaker: Hilary Vogt, PharmD, BCPPS – Indiana University Health